Accordingly, breast tumors are initially classified by immunohistochemistry (IHC) based on the expression of estrogen receptor (ER), progesterone receptor (PR), human epithelial growth factor receptor 2 (HER2) and the proliferative marker Ki-673. This evidence concerns the gene ESR1 and breast neoplasm.